Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
$2.28 - $3.03 $8,169 - $10,856
3,583 Added 121.87%
6,523 $18,000
Q1 2024

May 08, 2024

BUY
$2.61 - $4.49 $7,673 - $13,200
2,940 New
2,940 $8,000
Q2 2023

Aug 10, 2023

SELL
$1.9 - $4.3 $10,374 - $23,478
-5,460 Reduced 6.65%
76,677 $254,000
Q1 2023

May 09, 2023

BUY
$1.89 - $2.93 $150,967 - $234,039
79,877 Added 3534.38%
82,137 $174,000
Q4 2022

Feb 08, 2023

SELL
$2.48 - $3.43 $141,362 - $195,513
-57,001 Reduced 96.19%
2,260 $6,000
Q3 2022

Nov 04, 2022

BUY
$3.14 - $6.43 $144,754 - $296,423
46,100 Added 350.28%
59,261 $191,000
Q2 2022

Jul 29, 2022

SELL
$4.74 - $8.15 $122,050 - $209,854
-25,749 Reduced 66.18%
13,161 $64,000
Q1 2022

May 05, 2022

BUY
$6.47 - $9.57 $44,643 - $66,033
6,900 Added 21.56%
38,910 $295,000
Q4 2021

Jan 21, 2022

SELL
$9.02 - $13.5 $1.44 Million - $2.15 Million
-159,110 Reduced 83.25%
32,010 $294,000
Q3 2021

Nov 08, 2021

BUY
$13.71 - $17.18 $520,143 - $651,792
37,939 Added 24.77%
191,120 $2.72 Million
Q2 2021

Aug 04, 2021

BUY
$14.92 - $23.23 $1.51 Million - $2.35 Million
101,367 Added 195.64%
153,181 $2.54 Million
Q1 2021

May 10, 2021

BUY
$7.33 - $21.06 $299,892 - $861,627
40,913 Added 375.31%
51,814 $942,000
Q4 2020

Feb 08, 2021

SELL
$3.63 - $7.53 $107,037 - $222,037
-29,487 Reduced 73.01%
10,901 $82,000
Q3 2020

Nov 09, 2020

BUY
$3.29 - $4.58 $132,876 - $184,977
40,388 New
40,388 $155,000

Others Institutions Holding ORGO

About Organogenesis Holdings Inc.


  • Ticker ORGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 130,888,000
  • Market Cap $406M
  • Description
  • Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...
More about ORGO
Track This Portfolio

Track Russell Investments Group, Ltd. Portfolio

Follow Russell Investments Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.